Veklury (remdesivir) is a brand-name intravenous (IV) infusion prescribed to treat COVID-19 in certain adults and children. As with other drugs, Veklury can cause side effects, such as nausea and ...

Remdesivir was one of the first medications approved for treatment of COVID-19. Clinical studies evaluated its effectiveness, but did not generate conclusive results. A new analysis of the study data ...

Treatment with the antiviral remdesivir (Veklury) plus dexamethasone was linked to fewer deaths among patients hospitalized for COVID-19 compared with dexamethasone monotherapy, a retrospective study ...

Remdesivir was one of the first medications approved for treatment of COVID-19. Clinical studies evaluated its effectiveness, but did not generate conclusive results. A new analysis of the study data ...

FOSTER CITY, Calif. -- The world's largest randomized trial of COVID-19 treatments found "conclusive evidence" that remdesivir, a drug used to treat U.S. President Donald Trump when he fell ill, has ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Rate of major adverse cardiovascular events between 30 ...

The experimental drug remdesivir has been approved to treat hospitalized patients with severe Covid-19, the US Food and Drug Administration said in a letter on Friday. The experimental drug remdesivir ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The combination treatment reduced the need for ...